Indication

For treatment of adult patients with symptomatic anaemia associated with chronic kidney disease (CKD)

Medicine details

Medicine name:
roxadustat (Evrenzo)
SMC ID:
SMC2461
Pharmaceutical company
Astellas Pharma Ltd
BNF chapter
Nutrition and blood
Submission type
Full
Publication due date:
08 August 2022
SMC meeting date:
05 July 2022
Patient group submission deadline:
06 June 2022